NCT00741884 - A Study to Evaluate the Safety and Efficacy of Three Doses of a Controlled Release Formulation of Varenicline for Smoking Cessation | Biotech Hunter

Timeline

Start Date

August 31, 2010

Primary Completion Date

August 31, 2011

Study Completion Date

August 31, 2011

Conditions

Smoking Cessation

Interventions

DRUG

Varenicline Controlled Release 1.2 mg

Varenicline CR tablet 1.2 mg BID for 7 weeks

DRUG

Varenicline Controlled Release 1.8 mg

Varenicline CR tablet 1.8 mg BID for 7 weeks

DRUG

Varenicline Controlled Release 2.4 mg

Varenicline CR tablet 2.4 mg BID for 7 weeks

DRUG

Varenicline Immediate Release 1 mg

Varenicline IR tablet 1 mg BID for 7 weeks

DRUG

Placebo

Placebo BID for 7 weeks